Skip to content

Syndrome differentiation in the management of Chronic Stable Coronary Artery Disease (SCAD) to improve quality

Syndrome differentiation in the management of Chronic Stable Coronary Artery Disease (SCAD) to improve quality

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16010058
Enrollment
Unknown
Registered
2016-12-02
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable Coronary Artery Disease

Interventions

Sponsors

The first teaching hospital of Tianjin university of traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. without age limit; 2. diagnose as chronic SCAD at first visit; 3. heart function classification between II~III(CCS); 4. Be willing to accept Chinese herbal decoction; 5. sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. suffer from acute myocardial infarction (AMI) ,unstable angina or prior revascularization(i.e PCI,CABG) in the lateset 60 days; 2. have such diseases as follow: a.poorly controlled blood pressure even taken medicine(systolic pressure[SP]=180mmHg, diastolic pressure[DP]=100mmHg); b.severe arrhythmia(atrial fibrillation with rapid ventricular response, atrial flutter, paroxysmal ventricular tachycardia, etc); c.pulmonary heart disease, rheumatic heart disease, myocarditis, cardiomyopathy, aortic dissection, pulmonary embolism; 3.hyperthyreosis, cervical spondylosis, gallbladder-cardiac syndrome, gastroesophageal reflux, esophageal hiatal hernia, neurosis, climacteric syndrome and other diseases which would cause chest pain; 4. alanine transarninase(ALT) or serum creatinine(Scr) more than twice the normal reference value; 5. hemoglobin(Hb)<100g/L or have severe hematological system disease; 6. malignant tumor; 7. pregnant, lactating women or other women have reproductive requirement; 8. psychosis or cognition impairment person; 9. taken chinese medicine decoction in recent two weeks; 10. not take part in any other clinical trail.

Design outcomes

Primary

MeasureTime frame
A.EuroQol-5 Dimensions (EQ-5D);B.Four diagnostic method of TCM;

Secondary

MeasureTime frame
a.electrocardiograms(ECG);b.dynamic electrocardiogram;ultrasonic cardiogram;treadmill exercise testing (TET);

Countries

China

Contacts

Public ContactJingyuan Mao

The first teaching hospital of Tianjin university of traditional Chinese medicine

jymao@126.com+86 13820498886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026